UnitedHealth Group vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Minnetonka US largest healthcare company (NYSE: UNH) at $400.3B 2024 revenue with UnitedHealthcare + Optum; 2025 leadership transition (Hemsley return, Witty departure) and suspended outlook after Change Healthcare breach and elevated medical costs.
About
UnitedHealth Group is a Minnetonka, Minnesota-based healthcare and insurance conglomerate — publicly traded on the New York Stock Exchange (NYSE: UNH) as the largest healthcare company in the United States by revenue — reporting $400.3 billion in 2024 revenues and operating through two complementary platforms: UnitedHealthcare (health insurance serving 50+ million people) and Optum (health services including OptumHealth care delivery, OptumRx pharmacy benefit management, and OptumInsight technology and analytics). Employing approximately 400,000 people globally across 500+ locations, UnitedHealth Group has been transformed by a turbulent 2024-2025 period: the Change Healthcare ransomware cyberattack (February 2024) disrupted healthcare payments for 190 million Americans; UnitedHealthcare CEO Brian Thompson was murdered in December 2024 in New York City; and CEO Andrew Witty resigned for personal reasons in May 2025, with founder-era CEO Stephen Hemsley returning to lead the company and the 2025 earnings outlook suspended amid higher-than-expected medical costs.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.